Obicetrapib: reversing the tide of CETP inhibitor disappointments
JJP Kastelein, A Hsieh, MR Dicklin… - Current Atherosclerosis …, 2024 - Springer
Abstract Purpose of Review To discuss the history of cardiovascular outcomes trials of
cholesteryl ester transfer protein (CETP) inhibitors and to describe obicetrapib, a next …
cholesteryl ester transfer protein (CETP) inhibitors and to describe obicetrapib, a next …
Safety and Effectiveness of High‐Intensity Statins Versus Low/Moderate‐Intensity Statins Plus Ezetimibe in Patients With Atherosclerotic Cardiovascular Disease for …
H Soleimani, A Mousavi, S Shojaei… - Clinical …, 2024 - Wiley Online Library
Background It remains controversial whether adding ezetimibe to low/moderate‐intensity
statins has a more beneficial impact on the treatment efficacy and safety of patients with …
statins has a more beneficial impact on the treatment efficacy and safety of patients with …